We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRC icon
376
Kilroy Realty
KRC
$4.6B
$69.5K ﹤0.01%
1,859
-9
-0.5% -$368
TARS icon
377
Tarsus Pharmaceuticals
TARS
$2.6B
$68.2K ﹤0.01%
833
-75
-8% -$5.6K
XENE icon
378
Xenon Pharmaceuticals
XENE
$6.2B
$68K ﹤0.01%
1,517
-142
-9% -$5.96K
IRT icon
379
Independence Realty Trust
IRT
$3.93B
$67.7K ﹤0.01%
3,874
+22
+0.6% +$365
FUTU icon
380
Futu Holdings
FUTU
$14.5B
$67.3K ﹤0.01%
410
-27,942
-99% -$4.8M
TVTX icon
381
Travere Therapeutics
TVTX
$5.33B
$67.1K ﹤0.01%
1,757
-161
-8% -$5.24K
CGON icon
382
CG Oncology
CGON
$6.44B
$65.8K ﹤0.01%
1,585
-55
-3% -$2.28K
GRAL
383
GRAIL Inc
GRAL
$3.05B
$65.5K ﹤0.01%
765
-11
-1% -$950
VCYT icon
384
Veracyte
VCYT
$4.77B
$65.4K ﹤0.01%
1,553
-140
-8% -$5.64K
VERA icon
385
Vera Therapeutics
VERA
$2.37B
$63.6K ﹤0.01%
1,256
-117
-9% -$4.16K
EPR icon
386
EPR Properties
EPR
$4.9B
$62.9K ﹤0.01%
1,261
– –
SKT icon
387
Tanger
SKT
$4.71B
$62.6K ﹤0.01%
1,875
-16
-0.8% -$533
APLS
388
DELISTED
Apellis Pharmaceuticals
APLS
$62.4K ﹤0.01%
2,485
-232
-9% -$5.44K
RSG icon
389
Republic Services
RSG
$65B
$61.9K ﹤0.01%
+292
New +$62.8K
MRP
390
Millrose Properties Inc
MRP
$4.69B
$61.1K ﹤0.01%
2,044
-27
-1% -$847
COLD icon
391
Americold
COLD
$4.13B
$60.7K ﹤0.01%
4,719
+224
+5% +$2.75K
NHI icon
392
National Health Investors
NHI
$3.69B
$60.1K ﹤0.01%
787
+5
+0.6% +$383
IDYA icon
393
IDEAYA Biosciences
IDYA
$3.5B
$59.5K ﹤0.01%
1,722
-164
-9% -$5.23K
IRON icon
394
Disc Medicine
IRON
$3.03B
$58.9K ﹤0.01%
742
-6
-0.8% -$507
SGML icon
395
Sigma Lithium
SGML
$1.12B
$56.9K ﹤0.01%
+4,316
New +$37.2K
MLYS icon
396
Mineralys Therapeutics
MLYS
$2.31B
$56.4K ﹤0.01%
1,555
+129
+9% +$5.17K
SUPN icon
397
Supernus Pharmaceuticals
SUPN
$2.65B
$56K ﹤0.01%
1,126
-80
-7% -$3.89K
WVE icon
398
Wave Life Sciences
WVE
$1.11B
$55.8K ﹤0.01%
3,285
-139
-4% -$1.41K
BEAM icon
399
Beam Therapeutics
BEAM
$2.73B
$55.3K ﹤0.01%
1,994
-182
-8% -$4.64K
DYN icon
400
Dyne Therapeutics
DYN
$4.8B
$54.9K ﹤0.01%
2,806
-255
-8% -$4.83K
14 15
16
17 18

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.